Baird Maintains Outperform on Qiagen, Raises Price Target to $52
Benzinga Newsdesk 1 week ago
Analyst RatingsNewsPrice Target
Baird analyst Catherine Schulte maintains Qiagen (NYSE:QGEN) with a Outperform and raises the price target from $50 to $52.
Baird analyst Catherine Schulte maintains Qiagen (NYSE:QGEN) with a Outperform and raises the price target from $50 to $52.